James Xu
Overview
Explore the profile of James Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasqualini I, Pan X, Xu J, Austin C, Ibaseta A, Khan S, et al.
J Am Acad Orthop Surg
. 2025 Jan;
PMID: 39804973
Background: Total hip arthroplasty (THA) practices are evolving under the influence of the current value-based healthcare system and bundled payment models. This study aimed to (1) evaluate national trends in...
2.
He X, Li J, Xu J, Shan H, Shen S, Gao S, et al.
Acta Pharmacol Sin
. 2024 Sep;
46(3):565-574.
PMID: 39349764
Therapeutic antibodies are at the forefront of biotherapeutics, valued for their high target specificity and binding affinity. Despite their potential, optimizing antibodies for superior efficacy presents significant challenges in both...
3.
Tsai H, Xu J, Guo Z, Yi Y, Tian C, Que X, et al.
J Chem Inf Model
. 2024 Sep;
64(18):7046-7055.
PMID: 39225694
Accurate predictions of how strongly small molecules bind to proteins, such as those afforded by relative binding free energy (RBFE) calculations, can greatly increase the efficiency of the hit-to-lead and...
4.
Xu J, Neeman E, Thai K, Mishra P, Schlessinger D, Clancy H, et al.
J Hosp Med
. 2024 Apr;
19(6):449-459.
PMID: 38606546
Background: Hospital-acquired venous thromboembolism (HA VTE) is a preventable complication in hospitalized patients. Objective: We aimed to examine the use of pharmacologic prophylaxis (pPPX) and compare two risk assessment methods...
5.
Pasqualini I, Turan O, Emara A, Ibaseta A, Xu J, Chiu A, et al.
J Arthroplasty
. 2024 Feb;
39(8):2074-2081.
PMID: 38401607
Background: With the removal of total hip arthroplasty (THA) from the inpatient-only (IPO) lists, the orthopedic landscape across the United States has changed rapidly. Thus, this study aimed to: 1)...
6.
Leung J, French J, Xu J, Kachwalla H, Kaddapu K, Badie T, et al.
Heart Lung Circ
. 2024 Feb;
33(4):493-499.
PMID: 38365501
Background & Aim: Robotic-assisted percutaneous coronary intervention (R-PCI) has been increasingly performed overseas. Initial observations have demonstrated its clinical efficacy and safety with additional potential benefits of more accurate lesion...
7.
Morgan M, Thai J, Nencini S, Xu J, Ivanusic J
Mol Pain
. 2023 Dec;
19:17448069231222407.
PMID: 38073226
STOML3 is a membrane bound scaffolding protein that has been shown to facilitate the opening of mechanically sensitive ion channels and contribute to noxious mechanical sensation, allodynia and hyperalgesia. In...
8.
Kulhari S, Ahn A, Xu J, Rhee J, Cooper G
Cureus
. 2023 Nov;
15(10):e46902.
PMID: 37954716
Introduction Patients increasingly rely on online health information to understand and manage their diseases. Concerns about the quality and readability of these materials have been reported in the literature. Poor...
9.
Xu J, Lo S, Mussap C, French J, Rajaratnam R, Kadappu K, et al.
Am J Cardiol
. 2023 Jun;
201:16-24.
PMID: 37348152
Peripheral endothelial dysfunction is an independent predictor of adverse long-term prognosis after acute coronary syndrome. Data are lacking on the effects of oral P2Y12-inhibitors on peripheral endothelial function in non-ST-elevation...
10.
Pan X, Xu J, Rullan P, Pasqualini I, Krebs V, Molloy R, et al.
J Knee Surg
. 2023 Mar;
37(4):254-266.
PMID: 36963431
Value-based orthopaedic surgery and reimbursement changes for total knee arthroplasty (TKA) are potential factors shaping arthroplasty practice nationwide. This study aimed to evaluate (1) trends in discharge disposition (home vs...